Nutra Pharma Corp. Announces Designer Diagnostics Inc.' Clinical Trials to Be Conducted at National Jewish Medical and Research Center

Published: May 02, 2007

BOCA RATON, Fla.--(BUSINESS WIRE)--Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis, has today announced that its wholly owned medical devices subsidiary, Designer Diagnostics, will conduct clinical trials for its Tuberculosis (TB) and NonTuberculosis Mycobacterium (NTM) diagnostic Test Kits at National Jewish Medical and Research Center in Denver, Colorado.

Back to news